Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite.

@article{Scadding1986LowDS,
  title={Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite.},
  author={Glenis Kathleen Scadding and Jonathan Brostoff},
  journal={Clinical allergy},
  year={1986},
  volume={16 5},
  pages={483-91}
}
In a double-blind placebo-controlled cross-over trial, low dose sublingual therapy with house dust mite was effective in relieving symptoms in 72% of the group of patients with perennial rhinitis due to house dust mite (P less than 0.03). Following active treatment, there was a significant increase in morning peak nasal inspiratory flow rate (P less than 0.01) in those who improved (thirteen out of eighteen) and resistance to nasal provocation with house dust mite also increased, in some cases… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 68 extracted citations

Positive and negative AIT trials: What makes the difference?

Allergo journal international • 2018
View 1 Excerpt
Highly Influenced

From IgE to clinical trials of allergic rhinitis.

Expert review of clinical immunology • 2015
View 7 Excerpts
Highly Influenced

Current insights in allergen immunotherapy.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology • 2018

Similar Papers

Loading similar papers…